Infants of mothers with a high and of mothers with a low insulin response to glucose infusion. Glucose tolerance, insulin response and clinical appearance during the early neonatal period by Edström, Karin & Thalme, Bertil




Infants of mothers with a high and of mothers with a low
insulin response to glucose infusion. Glucose tolerance,
insulin response and clinical appearance during the early
neonatal period
Karin Edström, Bertil Thalme
Department of Obstetrics and Gynecology, Department of Endocrinology and
Metabolism, Department of Pediatrics, Karolinska Hospital, Stockholm,
Sweden
Received April l, 1974. Accepted April 29, 1974.
Diabetes mellitus in a pregnant woman affects the
development of the fetal pancreas [2] resulting in
hyperinsulinism of the newborn infant who also
often presents typical clinical traits [8, 23, 32],
Furthermore, diabetic women may produce
large-for-date infants long before their disturbed
carbohydrate metabolism is diagnosed [13, 17].
It is not known, however, at which stage in the
development of diabetes this effect on the fetus
appears.
CERASI and LUFT [4, 5] have defined "predia-
betes" äs a stage in which there is a normal
glucose tolerance but a decreased insulin
response to glucose infusion (GIT). In a
previous study [6] it was demonstrated that in a
group of low insulin responders — in which the
prediabetic individuals can be expected to be
found — the glucose tolerance remained normal
throughout pregnancy, while the insulin response
increased gradually. The glucose tolerance and
insulin response to an intravenous glucose load
(IVGTT) of the infants borne by these women
and by the control group of high responders
were studied. These results together with clinical
data on the infants and their mothers are presented
here.
l Material and methods
The groups consisted of 14 infants of mothers
with a high initial insulin response to glucose
(IHR) and 13 infants of mothers with a low
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response (ILR). Basic clinical data are presented
in Tab. I.
Before the study consent was obtained from the
parents.
1.1 Mothers
The classification of the mothers into high and
low responders was made on the basis of their
initial insulin response in the non-pregnant state
to a continuous glucose infusion (GIT) according
to the technique and criteria described by CE-
RASI and LUFT [4].
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Tab. I. Clinical data on 27 newborn healthy infants. 22 of them underwent an intravenous glucose tolerance test at





































































































































































































































































The high responders were slightly, but not
significantly, older than the low responders
(29.2 ± 3.5 years äs compared to 26.8 ± 3.0
years). Their mean weight before pregnancy was
60.1 ± 9.2 kg ( ± SD) äs compared to 52.7
± 5.7 kg for the low responders (p > 0.05) and
the mean body height 168.8 ± 5.2 cm and
165.0 ± 5.6 cm, respectively (p > 0.05). Their
urinary estriol excretion was followed weekly
during the latter half of the pregnancy and the
blood levels of chorionic somatomammotropin
(HCS) were determined at approximately 22 and
36 weeks pregnancy in 20 women.
1.2 Infants
a) At delivery. Immediately at birth the cord
was clamped in 9 IHR and 9 ILR and utnbilical
venous blood was drawn to determine glucose
and insulin. In 5 IHR and 7 ILR plasma glucose
was also determined in umbilical arterial blood at
birth and in femoral vein blood at 20, 40, 60 and
120 min age.
b) IVGTT. In 11 IHR and 11 ILR an IVGTT
was performed 4—24 hours after birth (Tab. I).
The lower time limit was chosen to avoid the
first intense period of metabolic adaptation after
birth. The upper time limit was set at 24 hours,
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since after this time the difference in k-value at
IVGTT between infants of diabetic mothers and
those of healthy mothers has been reported to
diminish [20,26]. In the remaining 5 infants the
IVGTT could not be performed within those time
limits. All infants were fasting except infant
No. 10, who had been fed with 10 ml of a 5%
glucose solution approximately 6 hours before
the test. No mothers received any glucose solution
during the delivery, but they were not fasted.
Glucose in a dose of 1.5 g per kg body weight in
a 25—50 per cent solution was injected either via
a scalp vein in 11 infants or through a catheter
inserted in the umbilical artery in the other 11.
There was no difference between the groups with
regard to the route of glucose injection or the
time required for the injection. The mean in-
jection time was 7.8 min (ränge 3—14 min).
Capillary blood samples to determine glucose
were collected at 0, 10, 20, 30, 40, 50 and 60 min
after the Start of the injection.
c) Insulin response at IVGTT. In 9 IHR and
10 ILR an umbilical vein catheter was inserted
at the IVGTT and introduced into the vena cava
well above the hepatic veins. Venous blood
samples, 1.5—3 ml, were drawn into heparfnized
test tubes at 0, 5, 10 and 20 min, centrifuged and
stored for later insulin determinations.
1.3 Laboratory methods
Blood glucose was determined by a glucose
oxidase method using a commercial preparation
(KABI Reagens, Stockholm). Plasma glucose was
determined using the same method adapted for
microliter volumes [27]. Plasma insulin meas-
urements were carried out at the Department of
Endocrinology and Metabolism, Karolinska
Hospital, using the double radioimmunoassay of
HALES and RÄNDLE [14]. Urinary estriol was
determined by a modification of BELING'S tech-
nique [31] and HCS was measured using a
commercial preparation (Phadebas®, PHARMACIA,
Sweden) at the Hormone Laboratory, Karolinska
Hospital.
1.4 Clinical neonatal score
The scoring System developed earlier [28] for
evaluating infants of diabetic mothers (IDM),
Tab. II. Neonatal scoring System.
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was adapted for application to these infatits·.. The
criteria chosen are listed in Tab. II, and they are
more frequently recorded in IDM than in a
population of infants of healthy mothers [8,
23],
For the birth weight/gestational age criterion the
distribution curves for newborn Swedish infants
computed by ENGSTRÖM and STERKY [10] was
used. Criteria Nos. 3—7 were recorded using the
notes in the hospital charts during the first 5 days
äs well äs a personal exaijiination of the infant at
least once and usually twice by one of us. One or
usually several blood glucose values were re-
corded for each infant and the lowest value
recorded was used. Two criteria have been
added to the ones originally used [28], namely a
recorded high k-value at IVGTT (^1.4 per cent)
and a high immediate insulin response at the
IVGTT (exceeding 100 per cent of fasting value
at 5 min).
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1.5 Statistical methods
The k-value at IVGTT was calculated according
to the formula:
0.693 100kt= *
where t ^ is the half-life time for blood glucose
(in absolute values) during the first hour after
the injection [15].
Comparisons o£ mean values for the groups were
made by MANN-WHITNEY'S ranking test. Ana-
lyses o£ changes within the groups were made by
pairwise comparison. For methods and tables
used, see SNEDECOR and COCHRAN [24].
2 Results
2.1 Mothers during pregnancy
The mean weight increase during pregnancy was
, 12.5 ± 2.7 and 11.3 ± 4.2 kg for high and low
responders respectively (p > 0.05). There was
no difference in urinary estriol excretion and no
individual pathological decrease was seen. The
HCS levels in plasma were also normal, in the
36th week mean values were 5.6 i 0.8 and
6.1 ± 1.1 microgram/ml respectively (p > 0.05).
The duration of labor was identical, 9.4 ± 6.6
hours in high and 9.3 ± 6.2 hours in low re-
sponders. No mothers had a k-value below 1.0
during or after pregnancy. For a more detailed
description of changes in insulin response during
pregnancy, see EDSTRÖM, CERASI and LUFT [9],
2.2 Infants
a) Fetal and neonatal conditions. Fetal brady-
cardia was recorded in two infants during labor
(Nos. 27 and 29), fetal tachycardia and meconium-
stained amniotic fluid in one (No. 24ä), and
meconitim-stained amniotic fluid alone in an-
other infant (No. 11).
The AP GAR score was normal in all infants at
birth, except two (Nos. 24a and 27 a) who
scored 6 points each. Minor disturbances were
registered in the breathing performance of 5
infants (Nos. 10, 14, 23, 28 and 29) but they all
disappeared within 40 minutes. No differences
were seen in rectal temperature, pulse or respi-
ratory rate between the IHR and ILR. The mean
birth weight did not differ significantly between
the two groups, but the postnatal weight loss was
more pronounced in ILR (p < 0.05). The
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Fig. 1. Individual plasma glucose levels at delivery and during the following two hours in five IHR (open circles) and
seven ILR (closed circles). The numbers in the graph refer to the infants' numbers in Tab. I. MV = maternal vein,
UV = umbilical vein, UA = umbilical artery.
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Tab. III. Mean values ± SD for plasma Insulin and blood glucose at delivery (UV) and during IVGTT in infants of high
insulin responders (IHR) and in infants of low insulin responders (ILR).



























































































Tab. IV. Mean values ± SD for k-values and plasma insulin increase during IVGTT in infants of high responders (IHR)
















Insulin increase during IVGTT,
μΐΐ/ml plasma





























* Increase within the group is significant with p < 0.025
** Increase within the group is significant with p < 0.05
similar fashion in both groups during the first
2 hours after birth (Fig. 1).
The mean values of plasma insulin in UV and
corresponding glucose values did not differ
between IHR and ILR (Tab. III). Prior to the
IVGTT the insulin values showed a non-sig-
nificant increase of about 5 micro U per ml from
the UV values and the glucose values decreased
significantly (p < 0.001 in both groups).
b) IVGTT. The mean k-value for IHR was
1.11 + 0.45 and that for ILR 1.40 ± 0.64, the
difference being noii-significant (Tab. IV). In-
dividual k-values are given in Tab. I. Five ILR
and 2 IHR had a k-value above 1.4 (Fig. 2).
Mean plasma insulin and blood glucose levels
during the IVGTT are given in Tab. III. The
differences found between the groups are not
significant. The mean increase of plasma insulin
above the fasting level at 5 min after the glucose
injection (the immediate insulin response) was
32.0 ± 35.7 micro U per ml for ILR and 17.2
± 24.2 micro U per ml for IHR (Tab. IV), but
again there was no significant difference between
the groups. The same was true for the total
insulin increment (Δϊο_2^). However, within the
group of ILR the insulin increase at 5 min was
significant at 2.5% levej. and later at 5% level
while the response within the IHR was not
significant.
The individual insulin responses, expressed s
per cent increase above the fasting value, are
shown in Fig. 3. Among the IHR only l infant
out of 9 showed an increase in plasma insulin at
5 min that exceeded 100% of the fasting value; all
the others had a response of less than 75%. This
infant had the highest k-value in that group but a
J. Perinat. Med. 3 (1975)
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Fig. 2. Distribution of k-values (kt). Striped bars denote k-values of IHR and dotted bars k-values of ILR. The
unfilled bars in the back-ground denote k-values of 26 IDM in an earlier study by THALME and EDSTRÖM [30].
Insulin increase
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glucose level of only 187 mg per 100 ml blood at
10 min after the Start of the glucose injection.
Among the ILR 6 infants out of 10 showed an
insulin response of more than 100% at 5 min.
There was no correlation between the infant's
k-value and its birth weight (r = 0.12, n = 22),
nor between their k-values and immediate insulin
responses (r = 0.02, n = 19). Neither was there
any correlation between their insulin responses
and birth weight (r = —0.10, n = 19).
c) Neonatal score. The sum'of scoring points
was calculated for each infant, and the distribution
of these individual sums within the groups is
shown in Fig. 4. Since the k-value and the im-
mediate insulin response could not be determined
in all infants, three different scoring sums were
calculated. The first includes the. first seven
scoring criteria (l—7), all of which were cal-
culated for each infant studied. The second in-
cludes the first seven criteria + k-value (l—8)
and the third the first seven criteria.+ k-value
+ immediate insulin response (l—9). The mean
Fig. 3. Insulin increase during IVGTT, expressed äs a
percentage of fasting values in 9 IHR (open circles) and
10 ILR (closed circles).
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of infonts
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M=1.3




0 1 2 3 4 5 6 points
Sum of scores 1-8
M=2.5
0 1 2 3 4 5 6 0 1 2 3 4 5 6 points




• · r0 1 2 3 4 5 6 ' 0 1 2 n3 4 5 6 points
IHR ILR
sums of the first seven criteria were 0.9 ±1.0
and 1.5 ± 1.3 for IHR and for ILR respectively
(p > 0.05). When the k-value was added the
mean sums for both groups increased and
finally, when all 9 criteria were added together,
the mean sum for ILR increased further so that a
significant difference was obtained between the
groups (IHR = 1.3 ± 1.6 and ILR = 2.6 ± 1.8,
p < 0.01).
The frequency of each criterion in the two groups,
expressed äs a percentage of the maximal score
possible for the whole group, is shown in Fig. 5.
The criterion high birth weight/gestational age,
which selects large-for-date infants, is the only
criterion seen more often in the IHR. All other
criteria were equally often or more frequently
encountered in the ILR group, particularly the
criteria hyperexcitability, hypoglycemia, high
Fig. 4. Distribution of the individual sums of scores for
IHR and ILR. The top diagram includes all 27 infants with
scores calculated for the first 7 criteria in Tab. II, the
middle diagram includes 22 infants with 8 criteria and the
bottom diagram 19 infants with all criteria. M = median
value for the group.
Birth weight/gestational age
"Diabetic fetopathy"





k-value at IVGTT, >1.4
Percentual insulin response
\
10- 20 30 40%
I H R
10 20 30 40 50 60%
I L R
Fig. 5. The proportion of the total scoring sum for each criterion found in each group. The first criterion refers to
the cases with a birth weight ^ 90th percentile (see Tab. II)
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k-value and insulin response. The two latter are increased, we could expect to find a significant
definitely the most frequent ones but no corre- difFerence between the ILR and the IHR.
lation was obtained between them. Eight out of In the same way the imm^diate insulin response
10 ILR showed either one or both of these showed a somewhat higher mean value for ILR,
criteria äs compared to only 2 out of 9 IHR, and although the difFerence was not significant. No
these distributions differ significantly (p < 0.005) correlation was found between the k-values
when analyzed by the chi square test. at IVGTT and the immediate insulin respon-
ses. This is different from what has been reported
for insulin and k-value in adults [16, 30] and in
3 Discussion older chüdren ^5], suggesting that the k-value
Women who deliver large or malformed in normal newborn infants is normally more
babies have been reported to run a higher risk influenced by factqrs other than the insulin
than others of developing clinical or chemical response. MÖLSTEDT-PEDERSEN and JÖRGEN-
diabetes mellitus later on [13,17, 22]. However, SEN [21] found a positive correlation between
these observations were not based on studies of these two factors, but they measured the insulin
the carbohydrate tolerance during pregnancy, at a later stage (12 min after the glucose injection)
and the occurrence of a transient gestational and their group also included 50 per cent of
diabetes might have passed unnoticed. The latter IDM.
^cpndition is well known both to afFect the in- A number of clinical indications and routine
fant's glucose tolerance [3, 11, 19] and to cause kboratory findings, known to appear in IDM
Symptoms of diabetic fetopathia [23]. It is not during the first few days, were evaluated by a
known, though, whether the infant of a truly scoring System which has previously been applied
prediabetic woman might be aflected in the same to such infants [28] who scored a significantly
way during pregnancy. higher sum than infants of healthy mothers. All
The low insulin response to GIT in healthy the criteria except high birth weight for gestational
subjects, which has been used here äs the age (or large-for-date infants) were somewhat
criterion for selecting the mothers, is postulated more commonly registered in the ILR but the
to be typical of — even if not always identical groups did not differ significantly, neither äs to
with — a prediabetic state [5]. Recently, the mean sum nor the distribution of the score.
CERASI and LUFT [6] through linear follow-up When the criteria high k-value and high insulin
studies carried out over some years have shown response were added, the two groups of infants
that a large proportion of the low responders showed some difference. These two criteria
develop transient or permanent signs of carbo- _ either one or both of them — were found in
hydrate intolerance. None of the low responders 9 Out of 11 ILR and only in 2 out of 11 IHR, and
studiedheredevelopedanysignsofapatholo- added together they seem to be significantly
gical glucose tolerance during the pregnancy related to the presence of a low insulin response
in question, and consequently any recorded to glucose in the mother.
"diabetogenic" effect on their infants might The normal human fetal pancreas has been
be considered related to the prediabetic shown to respond poorly to glucose both in
stage. vitro [18] and in vivo [29] despite the fact that
The mean k-value at IVGTT was somewhat but its capacity for synthesizing insulin seems to be
not significantly higher in the ILR than in the normal [7, 12]. In newborn infants of healthy
IHR. However, the mean value and the distribu- mothers this poor response persists at least for
tion of the k-values in the ILR group (Fig. 4) the first few days of life while IDM show a
was almost identical to that previously reported by marked and prompt insulin release after the same
THALME and EDSTRÖM [28] for a group of IDM glucose Stimulus [3, 21]. This has been related to
whose mothers were very rigidly controlled and the exposure of the fetus in a diabetic pregnancy
had almost normal blood glucoße levels in the to a sustained hyperglycemia [23], but recently
last trimester. Thus, if the size of the groups is ASPLUND [1] has shown that also a minor and
J. Perinat. Med. 3 (1975)
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intermittent maternal hyperglycemia during the
latter part of pregnancy can increase the sen-
sitivity of the fetal pancreas to glucose. The
mothers mentioned here all had normal glucose
tolerance and normal fasting glucose levels, but
the k-values at IVGTT in late pregnancy were
slightly lower in the low responders and con-
sequently their postprandial blood glucose levels
might have been repeatedly higher than those
of the high responders.
The tendencies here described in the infants,
namely a higher glucose tolerance and a more
pronounced initial insulin response to glucose in
ILR, should at present not be interpreted äs
being more than tendencies. The k-value at
IVGTT in the newborn infant is also influenced
by factors other than the insulin secretion from
the pancreas. It is also subject to a wide normal
Variation and the sample should be enlarged in
order to see whether the groups really do differ
in k-value. If this can be confirmed it could be of
considerable clinical value. The presence of a
high k-value and/or an increased initial in-
sulin response during an IVGTT in the
neonate would then be an important clue for
the detection of a prediabetic state in the
mother. It seems that this might be an even
earlier indication from the infant of a disturbed
carbohydrate metabolism in the mother than
for instance a high birth weight.
Summary
Diabetic mothers affect their offspring during pregnancy,
sometimes giving rise to the complete Symptoms of
diabetic fetopathia with the typical appearance of the child
high birth weight, hyperinsulinism, etc. Some of these
traits have also been reported to appear in the infants some
time before the onset of diabetes in the mother, but no
prospective study of infants born to truly prediabetic
mothers has yet been reported. Thus it is not possible to
say whether or not the previously reported effects are
related to an undetected, subclinical diabetes in the mother.
A prospective study of the insulin response to glucose
during pregnancy [9] has been previously published,
which included 11 women with a low insulin response to
glucose infusion (GIT) — a prediabetic type of insulin
response according to the definition of CERASI and LUFT
[5] — and a control group of 14 women with a high
insulin response to glucose infusion. In the following the
neonatal findings in these 13 infants of low insulin re-
sponders (ILR) and 14 infants of high responders (IHR)
are reported.
During pregnancy all the mothers maintained a normal
glucose tolerance äs determined by intravenous glucose
tolerance tests (IVGTT) and they had normal blood levels
of HCS and a normal excretion of estriol in urine.
Blood samples for determination of glucose and insulin in
blood were collected from the infants at birth, during the
first two hours and at an IVGTT carried out on 22 infants
at 4—24 hours of age. The glucose tolerance test was
performed by injecting 1.5 g glucose per kg body weight.
In 19 infants plasma insulin was determined· during the
IVGTT. At birth and during the first week all infants were
evaluated clinically to determine whether any of the
criteria l—7 seen in Tab. II were present. Each infant
received a sum of scores ranging from 0 to a theoretical
maximum of 11. For the majority of infants it was possible
to evaluate the k-value at IVGTT and to classify the
immediate insulin response into high or low (Tab. II),
making the maximum score sum 13.
Blood glucose was determined using a glucose oxidase
method, and plasma insulin using a radioimmunoassay
technique.
The immediate insulin response was defined äs the increase
above fasting value of insulin at 5 min after the Start of the
injection. A lower limit of 100% above the fasting value
was arbitrarily chosen for a high insulin response. Also
arbitrarily, a lower limit of 1.4 was set for what was con-
sidered a high k-value at IVGTT.
The birth weight was slightly but not significantly higher
among the IHR, but the weight loss during the first days
was more pronounced in the ILR.
The umbilical levels of insulin and glucose and correspond-
ing fasting levels at IVGTT (Tab. III) did not differ
between the groups. Insulin did not change significantly
before the IVGTT, while glucose decreased rapidly and
uniformly during the first two hours (Fig. 1).
The k-value tended to be higher in the ILR, 1.40 ± 0.64
äs compared to 1.11 ± 0.45 in IHR. This difference,
however, was not quite significant. The plasma insulin
increased significantly during the first 20 min in ILR,
while in the IHR the responSe was lower and the increase
not significant (Tab. IV). The difference in response
between the groups was not significant. There was no
correlation between the birth weight, k-value or insulin
response. The scoring sum for the seven clinical criteria
was higher in the ILR, but the difference between the
groups was not significant until the criteria 8 and 9 were
added (Fig. 3).
The findings reported above indicate that the infants
of low insulin responders — which would include the
prediabetic individuals — might be affected during
their fetal life in a way similar to infants of diabetic
J. Pcrinat. Med. 3 (1975)
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mothers, at least concerning theit glucose tolerance
and ability to respond rapidly to a glucose Stimulus
by an increase in insulin Output. This finding could
be an important clue for the detection of a prediabetic
state in the mother — probably more important than a
high birth weight.
Keywords: Glucose infusion, Glucose tolerance, Infants, Insulin response, Newborn, Prediabetics.
Zusammenfassung
Untersuchungen über Neugeborene von Müttern mit
hoher und niedriger Insulinausschüttung nach Glu-
coseinfusion. Glucosetoleranz, Insulinausschüttung
und klinisches Verhalten während der frühen Neo-
natalperiode.
Diabetische Mütter beeinflussen ihre Nachkommenschaft
während der Schwangerschaft, wobei manchmal das voll
entwickelte Bild der diabetischen Foetopathie mit dem
typischen Erscheinungsbild beim Neugeborenen, hohes
Geburtsgewicht, Hyperinsulinismus usw. entsteht. Es ist
bekannt, daß einige dieser Merkmale schon vor dem Auf-
treten des mütterlichen Diabetes beim Kind beobachtet
^verden, es ist jedoch noch keine prospektive Studie an
tvindern von tatsächlich prädiabetischen Müttern durch-
geführt und mitgeteilt worden. Daher ist es auch nicht
möglich, zu entscheiden, ob die zuvor angesprochenen
Veränderungen auf einen unentdeckten, subklinischen
Diabetes mellitus der Mutter zurückgeführt werden
können oder nicht.
Kürzlich wurde eine prospektive Untersuchung über die
Insulinausschüttung nach Glucoseapplikation während der
Schwangerschaft [9] publiziert, in der 11 Frauen mit
niedriger Insulinsekretion nach Glucoseinfusion — ent-
sprechend der Definition von CERASI und LUFT [5] ein für
Prädiabetes typisches Verhalten des Inselorgane s — und
eine Kontrollgruppe von 14 Frauen mit hoher Insulin-
sekretionsrate nach Infusion berücksichtigt wurde. Im
folgenden werden die Befunde jener 13 Neugeborener,
deren Mütter eine niedrige Insulinsekretionsrate (ILR)
zeigten und jener 14 Neugeborener mit hohen mütterlichen
Sekretionsraten (IHR) mitgeteilt.
Alle Mütter hatten aufgrund intravenöser Glucosetoleranz-
tests konstant normale Zuckertoleranzwerte während der
Schwangerschaft, normale HCS-Spiegel im Blut und die
Östrogenausscheidung im Urin lag ebenfalls im Norm-
bereich. Von den Neugeborenen wurden zum Zeitpunkt
der Geburt, während der ersten 2 Lebensstunden und bei
22 Neugeborenen A—24 Stunden nach der Geburt im
Rahmen eines intravenösen Glucosetoleranztestes Blut-
proben zur Bestimmung von Glucose und Insulin abge-
nommen. Beim Glucosetoleranztest wurden 1,5 g Glu-
cose/kg Körpergewicht i. v. verabfolgt. Bei 19 Kindern
konnte während des intravenösen Glucosetoleranztestes
das Plasmainsulin bestimmt werden. Bei der Geburt und
während der ersten Wochen wurden alle Kinder klinisch
im Hinblick auf das Vorkommen irgend eines der in
Tab. II angegebenen Kriterien untersucht. Jedes Neu-
geborene erhielt eine Notensumme, die zwischen 0 und
dem theoretischen Maximum 11 lag. In' der Mehrzahl der
Fälle konnte eine Bewertung der k-Werte beim i. v.
Glucosetoleranztest und eine Einstufung der Frühreaktion
des Inselorganes in hohe oder tiefe Sekretionsraten vor-
genommen werden (Tab. ll), was die höchste Bewertungs-
summe auf 13 ansteigen ließ. Der Blutzucker wurde mit
einer Glucoseoxidasemethode und das Plasmainsulin mit
einer Radioimmunoassay-Technik bestimmt. Als „Sofort-
reaktion des Inselorganes" wurde jener Insulinspiegel-
anstieg 5 min nach Beginn der Infusion definiert, der über
den Hungerwert hinausging. Als starke Reaktion des
Inselorganes wurde willkürlich der Insulinspiegel, welcher
100% über dem Insülin-Hungerwert lag, gewählt. Des-
gleichen wurde für die Definition eines hohen k-Wertes
beim i. v. Glucosetoleranztest eine untere Grenze von 1,4
willkürlich vorgegeben.
Bei den Kindern mit starker Reaktion des Inselorganes
lagen die Geburtsgewichte geringfügig aber nicht signi-
fikant höher, wohingegen der Gewichtsverlust während der
ersten Lebenstage in der Gruppe mit schwacher Reaktion
des Inselorganes deutlicher ausgeprägt war. Die Insulin-
und Glucosespiegel im Nebelschnurblut sowie die Hunger-
spiegel dieser Parameter beim i. v. Glucosetoleranztest
(Tab. III) unterschieden sich nicht in den beiden Stich-
proben. Der Insulinspiegel veränderte sich nicht signifikant
vor Beginn des i. v. Glucosetoleranztestes, wohingegen die
Glucosekonzentration schnell und einheitlich während der
beiden ersten Lebensstunden abnahm (Fig. 1). Die k-
Werte lagen in der Gruppe mit schwacher Reaktion der
Langhans-Zellen mit 1,40 i 0,64 eher höher im Ver-
gleich zu 1,11 Jt 0,45 in der Gruppe mit starker Reaktion.
Diese Differenz war jedoch nicht mehr signifikant. In der
Gruppe mit schwacher Reaktion stiegen die Plasmainsulin-
werte signifikant. In der Gruppe mit schwacher Reaktion
stiegen die Plasmainsulinwerte signifikant während der
ersten 20 Infusionsminuten an, während in der Gruppe
mit starker Antwort des Inselorganes der Anstieg nicht
signifikant und verzögert war (Tab. IV). Die Unterschiede
in den Reaktionsmustern der beiden Gruppen waren nicht
signifikant. Es fanden sich keine Korrelationen zwischen
dem Geburtsgewicht, den k-Werten oder der Insulinaus-
schüttung. Die Bewertungssumme für die 7 klinischen
Kriterien war in der Gruppe mit schwacher Reaktion
höher; der Unterschied zwischen den beiden Gruppen
war jedoch erst signifikant, wenn die Kriterien 8 und 9 ein-
bezogen wurden (Fig. 3).
Die mitgeteilten Beobachtungen weisen darauf hin, daß
Kinder von Müttern mit schwacher Reaktion des
Inselorganes — zu welchen die prädiabetische Schwan-
gere zählt — während ihres intrauterinen Lebens in
ähnlicher Weise beeinflußt werden wie Kinder von
diabetischen Müttern; dies gilt zumindest hinsichtlich
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ihrer Glucosetoleranz und ihrer Fähigkeit, auf einen
Glucosestimulus mit einer raschen Steigerung der
Insulinsekretion zu antworten. Dieser Befund könnte
ein wichtiger Hinweis bei der Suche nach dem mütter-
lichen Prädiabetes sein und ist vermutlich ein weit
wichtigerer Indikator als das zu hohe Geburtsgewicht.
Schlüsselwörter: Glucoseinfusion, Glucosetoleranz, Insulinausschüttung, Neugeborene, Prädiabetes, Kinder.
Resume
Les enfants nes de meres pr£sentant une forte reponse
insulinique et ceux n£s de mferes prosentant une faible
roponse insulinique a une perfusion de glucose.
Tolerance au glucose, roponse insulinique et aspect
clinique au cours dela p£riode n£onatale pr£coce
Les möres diabotiques lesent leurs enfants au cours de la
grossesse, parfois en donnant une image complete de
foetopathie diabetique: aspect typique de l'enfant, gros
poids de naissance, hyperinsulinisme. Certains de ces
symptomes ont 6te rapportes, parfois, chez des enfants
nes de meres dont le diabete n'£tait pas encore apparent.
Toutefois, il n'existe pas ä l'heure actuelle d'etude prospec-
tive portant sur des enfants nos de meres prosentant un
verkable prediabete. Des lors, il est impossible de dire si
les effets dejä citos sont ä mettre en correlation avec un
diabete maternal, subclinique et non diagnostiquo, ou pas.
Une etude prospective de la reponse insulinique ä la
perfusion de glucose pendant la grossesse [9] a dejä ete
publiee. Celle-ci comprenait 11 patientes presentant une
roponse insulinique faible ä la perfusion de glucose (GIT),
(ce qui correspond ä une reponse insulinique de type
prediabetique, selon la definition de CERASI et LUFT [5]),
eile comprenait outre, 14 femmes presentant une forte
reponse insulinique et utilisees comme groupe temoin.
Nous allons rapporter ici les decouvertes neonatales ob-
servees respectivement chez 13 enfants de meres ä reponse
faible (IHR) et chez 14 enfants de meres ä reponse forte.
Au cours de la grossesse, toutes les meres conserverent une
tolerance normale au glucose, ce qui fut rnis en evidence par
l'hyperglycemie provoquee par injection intraveineuse
(IVGTT), leur taux de HCS plasmatique demeura normal
ainsi que leur oestriolurie.
On pratiqua des mesures de la glycomie et de rinsulinomie
du nouveaune, ä la naissance et au cours des deux premieres
heures de la vie. On pratiqua une hyperglycemie provoquoe
par voie intraveineuse chez 22 nouveau-nes ä respective-
ment, 4 et 24 heures de vie. L'hyperglycemie provoquee
fut realisee par l'injection de 1,5 g de glucose par kilo de
poids. Chez 18 enfants, le taux d'insuline plasmatique fut
determine en meme temps. A la naissance et durant la
premiere semaine de vie tous les enfants furent soumis ä
des examens cliniques visant ä etudier la presence des
criteres l—7 rapportes dans le Tab. II. Chaque enfant
rec.u une quotation de 0 ä 11, qui est le maximum theorique.
Chez la majorite des enfants, une quotation de la valeur de
K au cours de l'hyperglycemie put etre raalisee, traduisant
une reponse insulinique immodiate forte ou faible, ce qui
porta le score maximum ä 13.
Mots-cles: Enfants, nouveau-ne, perfusion de glucose, prodiabete, reponse insulinique, tolerance au glucose.
La glycomie fut mesuree en utilisant une methode ä la
glucose oxydase. L'insulindmie fut evaluee par une tech-
nique radio-immunologique.
La roponse insulinique immodiate se definit comme suit:
augmentation de Pinsulinemie au dela de la valeur ä jeun,
5 minutes apras le debut de Tinjection de Sucre. La limite
inferieure de la reponse insulinique forte fut fixee de
facon arbitraire a 100% de la valeur de rinsulinemie ä
jeun. C'est aussi de fa$on arbitraire que nous avons fixe ä
1,4 la limite inforieure des valeurs de K elevees lors de
Phyperglycomie provoquee.
Le poids de naissance fut augmente de fagon nette mais non
significative chez les enfants nes de femmes IHR; tandis
que la perte de poids au cours des premiers jours du post-
partum fut plus importante chez les enfants nes de meres
ILR.
Les valeurs d'insulinemie et de glycemie ombilicales, et ces
memes valeurs ä jeun, mesurees au cours des hyperglycemies
provoquees (Tab. III) ne varierent pas d'un groupe ä
Tautre. L'insulinemie ne se modifia pas de fagon signifia-
cative avant Thyperglycemie intraveineuse, tandis que la
glycemie chuta rapidement et uniformement pendant les
premieres deux heures (Fig. 1).
La valeur de K avait tendance ä etre elevee chez les ILR:
(1,40 ± 0,64) en comparaison avec les IHR: (1,11 ± 0,45).
Cependant, cette difference ne fut pas significative. L'in-
sulinomie plasmatique augmenta de fagon significative
durant les 20 premieres minutes, chez les ILR, tandis que
chez les IHR, la reponse fut plus faible, et Paugmentation
non significative (Tab. IV). La difference de reponse entre
les groupes ne fut pas significative. II n'y eut pas de corre-
lation entre le poids de naissance, la valeur de K, et la
reponse insulinique. Le total des differents criteres cliniques
fut plus eleve chez les ILR, toutefois, la difference entre les
groupes ne fut pas significative tant qu'on n'y ajouta pas
les criteres 8 et 9 (Fig. 3).
Les faits rapportes ci-dessus montrent que les enfants
issus de meres ayant une reponse insulinique faible
(ce groupe correspondrait aux patientes prodiabetiques)
pourraient etre atteints durant leur vie intra-utorine
de la meme fagon que les enfants nes de meres diabe-
tiques surtout en ce qui concerne leur tolerance au
sucre et leur capacite de repondre rapidement a une
augmentation de leur glycemie par une secrotion
accrue d'insuline. Ce fait pourrait constituer un indice
important pour le depistage du prediabete maternel
et de valeur tres suponeure au poids de naissance
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